Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis

The Lancet Infectious Diseases

Volumn 16, Issue 7, 2016, Pages 797-808

  Platt, Lucy ^a   Easterbrook, Philippa ^b   Gower, Erin ^c   McDonald, Bethan ^a   Sabin, Keith ^d   McGowan, Catherine ^a   Yanny, Irini ^a   Razavi, Homie ^c   Vickerman, Peter ^e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Centre for Disease Analysis   (United States)

^d UNAIDS   (Switzerland)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMORBIDITY; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SELF INJECTION; SELF REPORT; SYSTEMATIC REVIEW; COINFECTION; GLOBAL HEALTH; HEPACIVIRUS; HIV INFECTIONS; ISOLATION AND PURIFICATION; META ANALYSIS;

COINFECTION; GLOBAL HEALTH; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; PREVALENCE;

EID: 84959124779     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00485-5     Document Type: Article

References (45)

1. How AIDS changes everything-MDG 6: 15 lessons of hope from the AIDS response 2015, UNAIDS, UNAIDS.
2. Global Statistics. UNAIDS UNAIDS, (accessed Oct 1, 2015). http://www.unaids.org/en/resources/campaigns/HowAIDSchangedeverything/factsheet.
3. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57:1333-1342.
4. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014, 61(suppl 1):S45-S57.
5. Hope VD, Eramova I, Capurro D, Donoghoe MC Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2014, 142:270-286.
6. Lavanchy D Evolving epidemiology of hepatitis C virus. Clinical microbiology and infection. Clin Microbiol Infect 2011, 17:107-115.
7. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet; 385: 117-71.
8. Doyle JS, Aspinall E, Liew D, Thompson AJ, Hellard ME Current and emerging antiviral treatments for hepatitis C infection. Bri J Clin Pharmacol 2013, 75:931-943.
9. Sulkowski MS Viral hepatitis and HIV coinfection. J Hepatol 2008, 48:353-367.
10. Valle Tovo C, Alves de Mattos A, Ribeiro de Souza A, et al. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus. Liver Int 2007, 27:40-46.
11. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis c virus infection: host, viral, and environmental factors. JAMA 2000, 284:450-456.
12. Shepard CW, Finelli L, Alter MJ Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
13. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000, 356:1800-1805.
14. Alter MJ Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006, 44(suppl 1):S6-S9.
15. Peters L, Klein MB Epidemiology of hepatitis C virus in HIV-infected patients. Curr Opin HIV AIDS 2015, 10:297-302.
16. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 2010, 14:e1024-e1031.
17. Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 2015, 15:819-824.
18. Vickerman P, Martin NK, Roy A, et al. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?. Drug Alcohol Depend 2013, 132:172-181.
19. Soriano V, Puoti M, Sulkowski M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007, 21:1073-1089.
20. Strader DB, Wright T, Thomas DL, Seeff LB Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147-1171.
21. Tien PC Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am Gastroenterol 2005, 100:2338-2354. Veterans Affairs Hepatitis CRCP, National Hepatitis CPONational Hepatitis CPO.
22. EASL Recommendations on Treatment of Hepatitis C 2014 European Association for the Study of the Liver, (accessed Oct 1, 2015). http://files.easl.eu/easl-recommendations-on-treatment-of-hepatitis-C.pdf.
23. Guidelines for screening, treatment and care for persons with hepatitis C 2014, WHO, World Health Organization, Geneva.
24. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
25. Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378:571-583.
26. World Drug Report 2014 2015, UNODC, United Nations Office on Drugs and Crime, Vienna.
27. Agarwal N, Dubey U, Agarwal A, Jaiswal R Hepatitis B or hepatitis C: the bigger threat in multiple infected HIV positive blood donors. J Clin and Diagn Res 2011, 5:766-768.
28. de Almeida Neto C, McFarland W, Murphy EL, et al. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion 2007, 47:608-614.
29. Karki S, Ghimire P, Tiwari BR, Shrestha AC, Gautam A, Rajkarnikar M Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal. Southeast Asian J Trop Med Public Health 2009, 40:66-70.
30. Myo K, San San O, Oo KM, Shimono K, Koide N, Okada S Prevalence and factors associated with hepatitis C virus infection among Myanmar blood donors. Acta Med Okayama 2010, 64:317-321.
31. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
32. Wiessing L, Ferri M, Grady B, et al. Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS One 2014, 9:e103345.
33. Kiyosawa K, Sodeyama T, Tanaka E, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991, 115:367-369.
34. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010, 375:1014-1028.
35. Martin NK, Vickerman P, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatology 2011, 54:1137-1144.
36. van der Helm JJ, Prins M, del Amo J, et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011, 25:1083-1091.
37. Wandeler G, Gsponer T, Bregenzer A, et al. Hepatitis C virus infections in the Swiss HIV cohort study: a rapidly evolving epidemic. Clin Infect Dis 2012, 55:1408-1416.
38. Martin TC, Martin NK, Hickman M, et al. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS 2013, 27:2551-2557.
39. Chandra T, Kumar A, Gupta A Prevalence of transfusion transmitted infections in blood donors: an Indian experience. Trop Doct 2009, 39:152-154.
40. Mabayoje VO, Muhibi MA, Akindele RA, Akinleye CA, Mabayoje PS, Babatunde OS Hepatitis C virus co-infection among people living with HIV/AIDS in a Nigerian Teaching Hospital. HIV AIDS Rev 2013, 12:102-125.
41. Simpore J, Ilboudo D, Samandoulougou A, Guardo P, Castronovo P, Musumeci S HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). J Med Virol 2005, 75:209-212.
42. Aceijas C, Rhodes T Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007, 18:352-358.
43. Kinkel H-T, Karmacharya D, Shakya J, et al. Prevalence of HIV, hepatitis B and C infections and an assessment of HCV-genotypes and two IL28B SNPs among people who inject drugs in three regions of Nepal. PLoS One 2015, 10:e0134455.
44. Micallef JM, Kaldor JM, Dore GJ Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006, 13:34-41.
45. Foster GR Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?. Addiction 2008, 103:1412-1413.